3rd Circ. Lets GSK Win Stand In Wellbutrin Pay-For-Delay Row
The Third Circuit on Wednesday turned down requests by buyers of Wellbutrin XL to redo its August decision upholding a win for GlaxoSmithKline PLC in litigation accusing the company of delaying...To view the full article, register now.
Already a subscriber? Click here to view full article